Advanced search×

Protein secretion systems in Pseudomonas aeruginosa: A wealth of pathogenic weapons

Int J Med Microbiol 300(8):10 (2010) PMID 20947426

Pathogenic microorganisms have to face hostile environments while colonizing and infecting their hosts. Unfortunately, they can cope with it and have evolved a number of complex secretion systems, which direct virulence factors either at the bacterial cell surface into the environmental extracellular milieu or into the host cell cytosol. Six different classes of secretion systems have been described so far, currently identified as type I secretion system (T1SS) up to type VI secretion system (T6SS). The Gram-negative opportunistic human pathogen Pseudomonas aeruginosa possesses a broad panel of secretion systems. Five of the six secretion machines characterized in Gram-negative bacteria are at P. aeruginosa disposal, sometimes in several copies. All these machines are dedicated to the specific secretion of exoproteins, which display various activities useful for bacterial adaptation to the environment or for bacterial pathogenicity. This review will summarize the functional organization of these different secretion systems, which could constitute potential targets for therapeutic treatment of patients infected by one of the most potent nosocomial pathogens identified nowadays.

DOI: 10.1016/j.ijmm.2010.08.005
Version: za2963e q8zac q8zb8 q8zc7 q8zd3 q8ze5 q8zf5 q8zg1

Similar articles you may find interesting…

  1. A virulence locus of Pseudomonas aeruginosa encodes a protein secretion apparatus.

    Science 312(5779):1526-30 (2006) PMID 16763151

    We found that a virulence locus (HSI-I) of Pseudomonas aeruginosa encodes a protein secretion apparatus. The apparatus assembled in discrete subcellular locations and exported Hcp1, a hexameric protein that forms rings with a 40 angstrom internal diameter. Regulatory patterns of HSI-I suggested that...
  2. Pseudomonas aeruginosa virulence and therapy: evolving translational strategies.

    Crit Care Med 37(5):1777-86 (2009) PMID 19325463

    Adjuvant therapies directed against virulence factors have the potential to improve outcomes in P. aeruginosa infections....